Background
Intradialytic hypotension (IDH), a common complication in hemodialysis (HD) patients, is associated with multiple risk factors including cardiac dysfunction and alterations of the peripheral autonomic nervous system. To what extent dysautonomia may contribute to the occurrence of IHD remains elusive. We sought to investigate the clinical utility of Sudocan®, a device that quantifies dysautonomia, in the prediction of IDH.
Methods
We conducted a prospective monocentric study in adult HD patients from July 2019 to February 2020. Dysautonomia was assessed by the measurements of hand and foot Electrochemical Skin Conductance (ESC) using Sudocan®, before HD.
The primary end point was the incidence of IDH (NKF/K-DOQI definition), according to the presence of a pathological hand and/or foot ESC value, during the 3-month study period.
Results
A total of 176 HD patients (64 ± 14 years old) were enrolled. Mean pre-dialysis hand and foot ESC were 45 ± 20 µS and 54 ± 22 µS, respectively. Thirty-five and 40% of patients had a pathological ESC at the hand and foot, respectively. IDH occurred in 46 patients. Logistic regression showed that pathologic pre-HD hand ESC was associated with an increased risk of IDH [OR = 2.56, IC95% (1.04-6.67), p = 0.04]. The cumulative risk incidence of IHD during the study was 5.65 [IC95% (2.04-15.71), p = 0.001] and 3.71 [IC95% (1.41-9.76), p = 0.008], with a pathological hand and foot ESC, respectively.
Conclusions
A pathological hand ESC, as assessed by a non-invasive Sudoscan® test is associated with an increased risk of IDH.